Brief

The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to add content to national risk-based control plans and randomised surveillance plans. The regulation requires Member States to specify species, sampling places, and national legislation on pharmacologically active substances in the plans. The amendment aims to ensure consistency and clarity in the submission of control plans and data by Member States. It modifies the heading of Article 8 and replaces Article 7 with a new provision specifying additional content for the national risk-based control plans and randomised surveillance plan.

This content is restricted.

Highlights content goes here...

This content is restricted.

Register of Delegated and Implementing Acts

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies